Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3553 publications

Clinical Trial Landscape of Stem Cell Therapy for Peripheral Arterial Disease.

Clinical Trial Landscape of Stem Cell Therapy for Peripheral Arterial Disease.

Journal: Stem cell reviews and reports
Published: November 17, 2025

Thromboangiitis obliterans: an update 2025

Thromboangiitis obliterans: an update 2025

Journal: Deutsche medizinische Wochenschrift (1946)
Published: November 10, 2025

An Unusual Case of Thromboangiitis Obliterans With Concurrent Deep Vein Thrombosis and Pulmonary Embolism.

An Unusual Case of Thromboangiitis Obliterans With Concurrent Deep Vein Thrombosis and Pulmonary Embolism.

Journal: Cureus
Published: November 10, 2025

Marijuana and Peripheral Vascular Disease: Pathophysiology, Clinical Evidence, and Cardiovascular Implications.

Marijuana and Peripheral Vascular Disease: Pathophysiology, Clinical Evidence, and Cardiovascular Implications.

Journal: Cardiology in review
Published: September 19, 2025

Midterm results of catheter-directed thrombolysis combined with drug-coated balloon dilatation in the treatment of femoral-popliteal thromboangiitis obliterans.

Midterm results of catheter-directed thrombolysis combined with drug-coated balloon dilatation in the treatment of femoral-popliteal thromboangiitis obliterans.

Journal: Vascular
Published: September 11, 2025

Indocyanine Green Angiography in the Evaluation of Surgical Amputation Level in Patients with Arterial Ulcers Due to Thromboangiitis Obliterans.

Indocyanine Green Angiography in the Evaluation of Surgical Amputation Level in Patients with Arterial Ulcers Due to Thromboangiitis Obliterans.

Journal: Medicina (Kaunas, Lithuania)
Published: August 19, 2025

MiR-21, miR-126 and miR-181b expression in Thromboangiitis obliterans.

MiR-21, miR-126 and miR-181b expression in Thromboangiitis obliterans.

Journal: VASA. Zeitschrift fur Gefasskrankheiten
Published: July 29, 2025

PAI-1 promotes thromboangiitis obliterans progression through NF-κB-NLRP3 pathway activation via HIF-1α-dependent signaling.

PAI-1 promotes thromboangiitis obliterans progression through NF-κB-NLRP3 pathway activation via HIF-1α-dependent signaling.

Journal: Microvascular research
Published: July 29, 2025

Endothelial activation in thromboangiitis obliterans: mechanisms and therapeutic horizons.

Endothelial activation in thromboangiitis obliterans: mechanisms and therapeutic horizons.

Journal: Frontiers in immunology
Published: July 17, 2025

Circulating Proteomic Panels for Noninvasive Diagnosis and Prognostication of Thromboangiitis Obliterans.

Circulating Proteomic Panels for Noninvasive Diagnosis and Prognostication of Thromboangiitis Obliterans.

Journal: Journal of proteome research
Published: July 01, 2025

Serum heavy metal levels from tobacco smoke and Buerger's disease.

Serum heavy metal levels from tobacco smoke and Buerger's disease.

Journal: Scientific reports
Published: June 26, 2025

Integrated metabolomics and network pharmacology study on Si-miao-yong-an Decoction in regulating sphingolipid metabolism and improving vascular injury on thromboangiitis obliterans.

Integrated metabolomics and network pharmacology study on Si-miao-yong-an Decoction in regulating sphingolipid metabolism and improving vascular injury on thromboangiitis obliterans.

Journal: Journal of ethnopharmacology
Published: June 14, 2025
Showing 1-12 of 3,553

Last Updated: 01/07/2026